Jazz Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.07.21	Horizons ETFs Rebalances Marijuana-Focused Index Etfs (PR Newswire)
01.07.21	FDA Approves Jazz's Rylaze To Treat Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma (RTTNews)
01.07.21	Jazz Pharmaceuticals Announces U.S. FDA Approval of Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (PR Newswire)
01.07.21	Jazz Pharmaceuticals Announces U.S. FDA Approval of Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (PR Newswire)
25.06.21	Jazz Pharma Announces Orphan Drug Exclusivity For Xywav To Treat Excessive Daytime Sleepiness (RTTNews)
25.06.21	Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution (PR Newswire)
25.06.21	Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral Solution (PR Newswire)
17.06.21	Jazz Pharma Updates 2021 Outlook To Include Recently Acquired GW Pharma (RTTNews)
17.06.21	Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plc (PR Newswire)
17.06.21	Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plc (PR Newswire)
14.06.21	Jazz Pharmaceuticals and Leading Cancer Organizations Collaborate to Launch First and Only Digital Hub Focused Exclusively on Emotional, Social and Physical Health Needs of Small Cell Lung Cancer ... (PR Newswire)
09.06.21	Jazz Pharmaceuticals Presents 18 Abstracts in Sleep Medicine at SLEEP 2021 (PR Newswire)
09.06.21	Jazz Pharmaceuticals Presents 18 Abstracts in Sleep Medicine at SLEEP 2021 (PR Newswire)
04.02.21	BIIB Pulls Plug On Parkinson's Drug, JAZZ Acquires GWPH, NBIX Ends Deal With VYGR, TYME Flies (RTTNews)
03.02.21	Jazz Pharma To Acquire GW Pharmaceuticals For $7.2 Bln - Quick Facts (RTTNews)
03.12.20	Jazz Pharma, PharmaMar Report Results Of Phase 3 Study Evaluating Zepzelca Plus Doxorubicin (RTTNews)
26.10.20	Jazz Pharma Buys FAAH Inhibitor Program Of SpringWorks Therapeutics - Quick Facts (RTTNews)
26.06.20	Biotech Stocks Facing FDA Decision In July 2020 (RTTNews)
16.06.20	FDA Nod For JAZZ's Drug, BYSI's PROTECTIVE-2 Trial Meets Goals, EDSA To Begin COVID-19 Drug Trial (RTTNews)
26.03.20	GILD Seeks To Revoke Coveted Status, ELOX Pauses Trial, PRQR On Watch (RTTNews)
26.02.20	Stock Alert: Will JAZZ's Downbeat Outlook Pull Down The Stock? (RTTNews)
19.02.20	BBI Awaits Data In Q2, BLPH Breathes Easy, Big Day For BXRX Tomorrow (RTTNews)
17.02.20	Jazz Pharma: FDA Grants Priority Review For Lurbinectedin (RTTNews)
19.12.19	PharmaMar And Jazz Pharma Sign License Deal For Lurbinectedin In U.S. (RTTNews)
26.09.19	Jazz Pharma Presents JZP-258 Phase 3 Study Data At World Sleep 2019 (RTTNews)
21.03.19	Jazz Pharma Gets FDA Nod For Sleep Disorder Drug Sunosi (RTTNews)
27.02.19	Biotech Stocks Facing FDA Decision In March (RTTNews)
26.11.18	Biotech Stocks Facing FDA Decision In December (RTTNews)
09.11.18	Jazz Pharma Submits MAA To European Medicines Agency For Solriamfetol (RTTNews)
28.09.18	Biotech Stocks Facing FDA Decision In October (RTTNews)
28.06.18	ACRX Gets EC Nod, AQXP Tanks As LEADERSHIP 301 Fails, ZSAN Catches Eye (RTTNews)
06.06.18	Jazz Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference (PR Newswire)
06.06.18	Jazz Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference (PR Newswire)
04.06.18	FDA Nod For LLY/INCY RA Drug, JAZZ Hits Right Tones, SLS' Study Stopped Early (RTTNews)
03.06.18	Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea (PR Newswire)
03.06.18	Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea (PR Newswire)
03.06.18	Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data for Xyrem® (sodium oxybate) in Pediatric Patients with Narcolepsy with Cataplexy (PR Newswire)
03.06.18	Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data for Xyrem® (sodium oxybate) in Pediatric Patients with Narcolepsy with Cataplexy (PR Newswire)
31.05.18	New Survey Highlights Lack of Awareness of Neurologic Effects Related to Excessive Sleepiness in Patients with Obstructive Sleep Apnea (PR Newswire)
31.05.18	New Survey Highlights Lack of Awareness of Neurologic Effects Related to Excessive Sleepiness in Patients with Obstructive Sleep Apnea (PR Newswire)
30.05.18	Face, Iris and Pulse Sensors on the Fast Track For The Next Steps Biometrics Security (PR Newswire)
24.05.18	Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS (PR Newswire)
24.05.18	Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS (PR Newswire)
10.05.18	Jazz Pharmaceuticals to Highlight Breadth of Research in Narcolepsy and Excessive Sleepiness in Obstructive Sleep Apnea at SLEEP 2018 Annual Meeting (PR Newswire)
10.05.18	Jazz Pharmaceuticals to Highlight Breadth of Research in Narcolepsy and Excessive Sleepiness in Obstructive Sleep Apnea at SLEEP 2018 Annual Meeting (PR Newswire)
10.05.18	Share of Millennials Living with Mom on the Rise (PR Newswire)
09.05.18	Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences (PR Newswire)
09.05.18	Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences (PR Newswire)
08.05.18	Jazz Pharmaceuticals Announces First Quarter 2018 Financial Results (PR Newswire)
08.05.18	Jazz Pharmaceuticals Announces First Quarter 2018 Financial Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.74	2.40 %	K V
UBS Group	28.02	1.26 %	K V
Part Grp Hldg	1’267.00	1.04 %	K V
Geberit	527.20	0.65 %	K V
ABB	49.32	0.61 %	K V
Zurich Insur Gr	552.80	0.04 %	K V
Nestle	76.08	-0.37 %	K V
CieFinRichemont	121.35	-0.45 %	K V
Sonova Hldg	301.00	-0.99 %	K V
Givaudan	3’835.00	-1.16 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Jazz Pharmaceuticals PLC

Aktien Top/Flop

Meistgelesene Nachrichten